BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 31031757)

  • 21. The inflammatory chemokines CCL2 and CCL5 in breast cancer.
    Soria G; Ben-Baruch A
    Cancer Lett; 2008 Aug; 267(2):271-85. PubMed ID: 18439751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of interferon-signalling halts cancer-associated fibroblast-dependent protection of breast cancer cells from chemotherapy.
    Broad RV; Jones SJ; Teske MC; Wastall LM; Hanby AM; Thorne JL; Hughes TA
    Br J Cancer; 2021 Mar; 124(6):1110-1120. PubMed ID: 33398063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by regulating PKA and PP2A.
    Bott A; Erdem N; Lerrer S; Hotz-Wagenblatt A; Breunig C; Abnaof K; Wörner A; Wilhelm H; Münstermann E; Ben-Baruch A; Wiemann S
    Oncotarget; 2017 Jul; 8(27):43897-43914. PubMed ID: 28159925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
    Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
    Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stiffness-dependent MSC homing and differentiation into CAFs - implications for breast cancer invasion.
    Saxena N; Chakraborty S; Dutta S; Bhardwaj G; Karnik N; Shetty O; Jadhav S; Zafar H; Sen S
    J Cell Sci; 2024 Jan; 137(1):. PubMed ID: 38108421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production.
    Escobar P; Bouclier C; Serret J; Bièche I; Brigitte M; Caicedo A; Sanchez E; Vacher S; Vignais ML; Bourin P; Geneviève D; Molina F; Jorgensen C; Lazennec G
    Oncotarget; 2015 Oct; 6(30):29034-47. PubMed ID: 26362269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the association of POSTN
    Lin S; Zhou M; Cheng L; Shuai Z; Zhao M; Jie R; Wan Q; Peng F; Ding S
    Int J Biol Macromol; 2024 May; 268(Pt 1):131560. PubMed ID: 38631570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein-Bound Polysaccharides from
    Jędrzejewski T; Pawlikowska M; Sobocińska J; Wrotek S
    Cell Physiol Biochem; 2020 Jun; 54(4):615-628. PubMed ID: 32559360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRβ Aptamer.
    Camorani S; Hill BS; Fontanella R; Greco A; Gramanzini M; Auletta L; Gargiulo S; Albanese S; Lucarelli E; Cerchia L; Zannetti A
    Theranostics; 2017; 7(14):3595-3607. PubMed ID: 28912898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of INFG/STAT1/NOTCH3 as γ-Mangostin's potential targets for overcoming doxorubicin resistance and reducing cancer-associated fibroblasts in triple-negative breast cancer.
    Lawal B; Wu AT; Chen CH; T A G; Wu SY
    Biomed Pharmacother; 2023 Jul; 163():114800. PubMed ID: 37141739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer-Associated Fibroblasts Autophagy Enhances Progression of Triple-Negative Breast Cancer Cells.
    Wang M; Zhang J; Huang Y; Ji S; Shao G; Feng S; Chen D; Zhao K; Wang Z; Wu A
    Med Sci Monit; 2017 Aug; 23():3904-3912. PubMed ID: 28802099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis.
    Jin K; Pandey NB; Popel AS
    Breast Cancer Res; 2018 Jun; 20(1):54. PubMed ID: 29898755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of GLUT3 promotes metastasis of triple-negative breast cancer by modulating the inflammatory tumor microenvironment.
    Tsai TH; Yang CC; Kou TC; Yang CE; Dai JZ; Chen CL; Lin CW
    J Cell Physiol; 2021 Jun; 236(6):4669-4680. PubMed ID: 33421130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
    Morein D; Erlichman N; Ben-Baruch A
    Front Immunol; 2020; 11():952. PubMed ID: 32582148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Embryonic protein NODAL regulates the breast tumor microenvironment by reprogramming cancer-derived secretomes.
    Dieters-Castator D; Dantonio PM; Piaseczny M; Zhang G; Liu J; Kuljanin M; Sherman S; Jewer M; Quesnel K; Kang EY; Köbel M; Siegers GM; Leask A; Hess D; Lajoie G; Postovit LM
    Neoplasia; 2021 Apr; 23(4):375-390. PubMed ID: 33784590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunomodulatory potential of Clinacanthus nutans extracts in the co-culture of triple-negative breast cancer cells, MDA-MB-231, and THP-1 macrophages.
    Nordin FJ; Pearanpan L; Chan KM; Kumolosasi E; Yong YK; Shaari K; Rajab NF
    PLoS One; 2021; 16(8):e0256012. PubMed ID: 34379689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SPARC in cancer-associated fibroblasts is an independent poor prognostic factor in non-metastatic triple-negative breast cancer and exhibits pro-tumor activity.
    Alcaraz LB; Mallavialle A; Mollevi C; Boissière-Michot F; Mansouri H; Simony-Lafontaine J; Laurent-Matha V; Chardès T; Jacot W; Turtoi A; Roger P; Guiu S; Liaudet-Coopman E
    Int J Cancer; 2023 Mar; 152(6):1243-1258. PubMed ID: 36346290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokines secreted by stromal cells in TNBC microenvironment as potential targets for cancer therapy.
    Malone MK; Smrekar K; Park S; Blakely B; Walter A; Nasta N; Park J; Considine M; Danilova LV; Pandey NB; Fertig EJ; Popel AS; Jin K
    Cancer Biol Ther; 2020 Jun; 21(6):560-569. PubMed ID: 32213106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNFα-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines.
    Shin SY; Nam JS; Lim Y; Lee YH
    J Biol Chem; 2010 Oct; 285(40):30731-40. PubMed ID: 20650898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.